Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lupin Pharmaceuticals Inc.

Division of Lupin Ltd.
www.lupinpharmaceuticals.com

Latest From MidaSol Therapeutics LP

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Lupin Ltd.
  • Senior Management
  • Vinita Gupta, CEO
    Paul McGarty, Pres.
  • Contact Info
  • Lupin Pharmaceuticals Inc.
    Phone: (866) 587-4617
    Harborplace Tower, 111 S.Calvert St.
    21st Fl.
    Baltimore, MD 21202
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register